semaglutide shots queen creek Weight Loss Injection semaglutide shots queen creek PRIME

TAKEAWAY Awareness of GLP-1 drugs intended for weight-loss purposes increased from 80% in 2024 to 91% in 2026 among US adults

The relationship between glutathione and magnesium is particularly intriguing

The SURMOUNT-1 trial for tirzepatide showed average weight loss of 15% of starting body weight at 36 weeks (roughly 8.5 months)

Options your provider may consider include extending the time between dose increases to give your gut more time to adapt, temporarily reducing the dose until constipation management strategies take effect, or switching between GLP-1 medications if one produces intolerable side effects

Monitor regulatory changes: Both US and Canadian policies regarding cross-border prescription purchases may evolve, particularly as generic semaglutide medications enter the Canadian market in 2026